Temporary bypass device aims to protect surgical connections in colorectal cancer
NCT ID NCT05632744
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This trial tests a temporary device called CG-100 that is placed inside the intestine during colorectal cancer surgery. The device is designed to protect the surgical connection while it heals, potentially reducing leaks and other complications. The study includes adults aged 22 to 75 who have been diagnosed with colorectal cancer and are scheduled for surgery. The main goal is to check whether the device is safe by monitoring for serious side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CG-100 Intraluminal Bypass Device
What this could lead to
If safe and effective, this device could help protect the surgical connection during colorectal cancer surgery, potentially reducing complications and improving recovery.
What could go wrong
This is a very small early-stage safety study with only 7 participants, so results may not apply to all patients. The device itself carries risks such as infection or device-related injury.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AMPLIFI: Web-Based Lifestyle Program for Cancer NCT04000880
- Bupivacaine + Dexmedetomidine for Pain After Col NCT06370949
- LIVELONG Trial: Ablative Therapy for GI Cancers NCT06101277
- Colonoscopy in Breast Cancer Survivors: NCT07678099
- mFOLFOX6+Bevacizumab+PD-1 for MSS Colorectal Can NCT04895137
- Precision Navigation for Cancer Screening Trial NCT07676383
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Soroka Medical Center
Rehovot, Israel